Thus, the extragonadal effects of FSH leading to increased cholesterol levels and adiposity in postmenopausal women could have indirectly led to enhanced atherosclerosis with arterial inflammation and calcification, dysfunctional vasa vasorum and PVAT, all potentially affecting AAA development. The gene discussed is BRD2; the disease is triple-A syndrome.